← FDA DRUG APPROVALS

FDA ANDA · ANDA203144

ULSPIRA

nitric oxide

Sponsor: AIRGAS THERAP

APPLICATION
ANDA203144
TYPE
ANDA
ORIGINAL APPROVAL
2023-07-27
LATEST ACTION
2023-07-27
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
GAS
MARKETING STATUS
Prescription

Products

ULSPIRAPrescription
NITRIC OXIDE 800PPM · GAS · INHALATION

Approval history

2023-07-27UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →